Correlation Between ATAI Life and ATyr Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATAI Life and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATAI Life and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATAI Life Sciences and ATyr Pharma, you can compare the effects of market volatilities on ATAI Life and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATAI Life with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATAI Life and ATyr Pharma.

Diversification Opportunities for ATAI Life and ATyr Pharma

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between ATAI and ATyr is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding ATAI Life Sciences and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and ATAI Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATAI Life Sciences are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of ATAI Life i.e., ATAI Life and ATyr Pharma go up and down completely randomly.

Pair Corralation between ATAI Life and ATyr Pharma

Given the investment horizon of 90 days ATAI Life Sciences is expected to generate 0.13 times more return on investment than ATyr Pharma. However, ATAI Life Sciences is 7.76 times less risky than ATyr Pharma. It trades about 0.04 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.3 per unit of risk. If you would invest  157.00  in ATAI Life Sciences on August 29, 2024 and sell it today you would earn a total of  12.00  from holding ATAI Life Sciences or generate 7.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy6.4%
ValuesDaily Returns

ATAI Life Sciences  vs.  ATyr Pharma

 Performance 
       Timeline  
ATAI Life Sciences 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ATAI Life Sciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, ATAI Life demonstrated solid returns over the last few months and may actually be approaching a breakup point.
ATyr Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ATyr Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, ATyr Pharma is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

ATAI Life and ATyr Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATAI Life and ATyr Pharma

The main advantage of trading using opposite ATAI Life and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATAI Life position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.
The idea behind ATAI Life Sciences and ATyr Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio